PhoreMost and o2h discovery collaborate to progress first-in-class drug discovery programs News - 21st June 2018
PhoreMost and NeoPhore Receive Innovate UK Funding to Support Development of a Novel Small-Molecule Cancer Immunotherapy Programme News - 27th April 2018
PhoreMost and Sixth Element Capital Announce Creation and Investment in NeoPhore, an Immuno-Oncology Company News - 15th November 2017